Vitamin D receptor expression controls proliferation of naïve CD8+ T cells and development of CD8 mediated gastrointestinal inflammation

BMC Immunology

Volumn 15, Issue 1, 2014, Pages

  Chen, Jing ^a   Bruce, Danny ^a,b   Cantorna, Margherita T ^a,c  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Center for Molecular Immunology and Infectious Disease   (United States)

Author keywords

CD8+ T cells; Inflammatory bowel disease; Proliferation; Vitamin D receptor

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 2; L SELECTIN; VITAMIN D; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; COLITIS; CONTROLLED STUDY; DIGESTIVE SYSTEM INFLAMMATION; DISEASE SEVERITY; DOWN REGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; INFLAMMATORY BOWEL DISEASE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COLITIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; RECEPTORS, CALCITRIOL;

EID: 84893662446     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-15-6     Document Type: Article

References (40)

1. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, Finlay BB. Host-Mediated Inflammation Disrupts the Intestinal Microbiota and Promotes the Overgrowth of Enterobacteriaceae. Cell Host and Microbe 2007, 2:119-129. 10.1016/j.chom.2007.06.010, 18005726.
2. Webb AR, Pilbeam C, Hanafin N, Holick MF. An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr 1990, 51(6):1075-1081.
3. Ardizzone S, Cassinotti A, Bevilacqua M, Clerici M, Porro GB. Vitamin D and inflammatory bowel disease. Vitam Horm 2011, 86:367-377.
4. Pappa HM, Gordon CM, Saslowsky TM, Zholudev A, Horr B, Shih MC, Grand RJ. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 2006, 118(5):1950-1961. 10.1542/peds.2006-0841, 3205440, 17079566.
5. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003, 17(12):2386-2392. 10.1210/me.2003-0281, 14500760.
6. Cantorna MT. Vitamin D, multiple sclerosis and inflammatory bowel disease. Arch Biochem Biophys 2012, 523(1):103-106. 10.1016/j.abb.2011.11.001, 3374859, 22085500.
7. Zella JB, McCary LC, DeLuca HF. Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch Biochem Biophys 2003, 417(1):77-80. 10.1016/S0003-9861(03)00338-2, 12921782.
8. Froicu M, Zhu Y, Cantorna MT. Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice. Immunology 2006, 117(3):310-318. 10.1111/j.1365-2567.2005.02290.x, 1782241, 16476050.
9. Bruce D, Cantorna MT. Intrinsic requirement for the vitamin D receptor in the development of CD8alphaalpha-expressing T cells. J Immunol 2011, 186(5):2819-2825. 10.4049/jimmunol.1003444, 3127166, 21270396.
10. Bruce D, Yu S, Ooi JH, Cantorna MT. Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int Immunol 2011, 23(8):519-528. 10.1093/intimm/dxr045, 3139478, 21697289.
11. Mayne CG, Spanier JA, Relland LM, Williams CB, Hayes CE. 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. Eur J Immunol 2011, 41(3):822-832. 10.1002/eji.201040632, 21287548.
12. Mahon BD, Wittke A, Weaver V, Cantorna MT. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 2003, 89(5):922-932. 10.1002/jcb.10580, 12874827.
13. Thien R, Baier K, Pietschmann P, Peterlik M, Willheim M. Interactions of 1 alpha,25-dihydroxyvitamin D3 with IL-12 and IL-4 on cytokine expression of human T lymphocytes. J Allergy Clin Immunol 2005, 116(3):683-689. 10.1016/j.jaci.2005.05.013, 16159643.
14. Yu S, Cantorna MT. The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci USA 2008, 105(13):5207-5212. 10.1073/pnas.0711558105, 2278204, 18364394.
15. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM, O'Garra A. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002, 195(5):603-616. 10.1084/jem.20011629, 2193760, 11877483.
16. Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002, 51(5):1367-1374. 10.2337/diabetes.51.5.1367, 11978632.
17. Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000, 374(2):334-338. 10.1006/abbi.1999.1605, 10666315.
18. Steinhoff U, Brinkmann V, Klemm U, Aichele P, Seiler P, Brandt U, Bland PW, Prinz I, Zugel U, Kaufmann SHE. Autoimmune intestinal pathology induced by hsp60-specific CD8 T cells. Immunity 1999, 11(3):349-358. 10.1016/S1074-7613(00)80110-7, 10514013.
19. Wiesel M, Oxenius A. From crucial to negligible: functional CD8(+) T-cell responses and their dependence on CD4(+) T-cell help. Eur J Immunol 2012, 42(5):1080-1088. 10.1002/eji.201142205, 22539281.
20. Filaci G, Fravega M, Negrini S, Procopio F, Fenoglio D, Rizzi M, Brenci S, Contini P, Olive D, Ghio M, et al. Nonantigen specific CD8(+) T suppressor lymphocytes originate from CD8(+)CD28(-) T cells and inhibit both T-cell proliferation and CTL function. Hum Immunol 2004, 65(2):142-156. 10.1016/j.humimm.2003.12.001, 14969769.
21. Menager-Marcq I, Pomie C, Romagnoli P, van Meerwijk JPM. CD8(+)CD28(-) regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. Gastroenterology 2006, 131(6):1775-1785. 10.1053/j.gastro.2006.09.008, 1950262, 17087950.
22. Shi Z, Okuno Y, Rifa'i M, Endharti AT, Akane K, Isobe KI, Suzuki H. Human CD8(+) CXCR3(+) T cells have the same function as murine CD8(+) CD122(+) Treg. Eur J Immunol 2009, 39(8):2106-2119. 10.1002/eji.200939314, 19609979.
23. Endharti AT, Okuno Y, Shi Z, Misawa N, Toyokuni S, Ito M, Isobe K, Suzuki H. CD8(+)CD122(+) Regulatory T Cells (Tregs) and CD4(+) Tregs Cooperatively Prevent and Cure CD4(+) Cell-Induced Colitis. J Immunol 2011, 186(1):41-52. 10.4049/jimmunol.1000800, 21098236.
24. Poussier P, Ning T, Banerjee D, Julius M. A unique subset of self-specific intraintestinal T cells maintains gut integrity. J Exp Med 2002, 195(11):1491-1497. 10.1084/jem.20011793, 2193537, 12045247.
25. Das G, Augustine MM, Das J, Bottomly K, Ray P, Ray A. An important regulatory role for CD4 + CD8 alpha alpha T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease. Proc Natl Acad Sci USA 2003, 100(9):5324-5329. 10.1073/pnas.0831037100, 154344, 12695566.
26. Yu S, Bruce D, Froicu M, Weaver V, Cantorna MT. Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proc Natl Acad Sci USA 2008, 105(52):20834-20839. 10.1073/pnas.0808700106, 2634903, 19095793.
27. Goldrath AW, Sivakumar PV, Glaccum M, Kennedy MK, Bevan MJ, Benoist C, Mathis D, Butz EA. Cytokine requirements for acute and basal homeostatic proliferation of naive and memory CD8(+) T cells. J Exp Med 2002, 195(12):1515-1522. 10.1084/jem.20020033, 2193554, 12070279.
28. Tsoukas CD, Provvedini DM, Manolagas SC. 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 1984, 224(4656):1438-1440. 10.1126/science.6427926, 6427926.
29. Rigby WF, Noelle RJ, Krause K, Fanger MW. The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis. J Immunol 1985, 135(4):2279-2286.
30. Rigby WF, Yirinec B, Oldershaw RL, Fanger MW. Comparison of the effects of 1,25-dihydroxyvitamin D3 on T lymphocyte subpopulations. Eur J Immunol 1987, 17(4):563-566. 10.1002/eji.1830170420, 3106071.
31. Rigby WF, Stacy T, Fanger MW. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 1984, 74(4):1451-1455. 10.1172/JCI111557, 425314, 6332829.
32. Alroy I, Towers TL, Freedman LP. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 1995, 15(10):5789-5799. 230831, 7565732.
33. Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 2006, 311(5769):1924-1927. 10.1126/science.1122927, 16484453.
34. Blattman JN, Grayson JM, Wherry EJ, Kaech SM, Smith KA, Ahmed R. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat Med 2003, 9(5):540-547. 10.1038/nm866, 12692546.
35. Feau S, Arens R, Togher S, Schoenberger SP. Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells. Nat Immunol 2011, 12(9):908-913. 10.1038/ni.2079, 3388550, 21804558.
36. Lemire JM, Adams JS, Sakai R, Jordan SC. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984, 74(2):657-661. 10.1172/JCI111465, 370520, 6611355.
37. Carlberg C, Molnar F. Current status of vitamin D signaling and its therapeutic applications. Curr Top Med Chem 2012, 12(6):528-547. 10.2174/156802612799436623, 22242854.
38. Welsh J. Cellular and molecular effects of vitamin D on carcinogenesis. Arch Biochem Biophys 2012, 523(1):107-114. 10.1016/j.abb.2011.10.019, 3295909, 22085499.
39. Yu S, Cantorna MT. Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice. J Immunol 2011, 186(3):1384-1390. 10.4049/jimmunol.1002545, 3127168, 21191070.
40. Davidson NJ, Leach MW, Fort MM, Thompson-Snipes L, Kuhn R, Muller W, Berg DJ, Rennick DM. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 1996, 184(1):241-251. 10.1084/jem.184.1.241, 2192682, 8691138.